Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the safety and tolerability of pharmaceutical compound (API 31510) topical cream topically applied to superficial basal cell carcinomas to obtain preliminary efficacy data for the treatment of superficial basal cell carcinomas by API 31510 topical cream. The study population will include one hundred and sixty (160) otherwise healthy male or female adults with one or more histologically confirmed superficial basal cell carcinoma lesions. One target lesion with an area of less than one inch will be designated for study treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00604890
Study type Interventional
Source Berg, LLC
Contact
Status Completed
Phase Phase 1/Phase 2
Start date March 2008
Completion date January 2010

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04552990 - Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma Phase 2
Active, not recruiting NCT03573401 - Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). Phase 3
Completed NCT03012009 - Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial N/A
Completed NCT02270645 - Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser N/A
Completed NCT00469417 - Metvix PDT Versus Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma Phase 3
Recruiting NCT05381597 - 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer Phase 2/Phase 3
Terminated NCT00994240 - Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC N/A
Completed NCT00189306 - Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream Phase 3
Recruiting NCT05157763 - A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma Phase 1/Phase 2
Recruiting NCT04744935 - Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma N/A
Completed NCT05628714 - A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma
Completed NCT00432185 - To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC Phase 2
Recruiting NCT01491711 - Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Phase 4
Completed NCT04470726 - Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma Phase 1/Phase 2
Completed NCT01325688 - PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities Phase 2
Recruiting NCT05713760 - Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults Phase 2